TLR4 and Insulin resistance: Insulin resistance, elicited by the binding of agonists to tumour necrosis factor receptor superfamily member 1A (TNFR1) and toll-like receptor 4 (TLR4), activate the JAK signalling pathway that phosphorylates serine at insulin receptor substrates 1 and 2 (IRS1, 2) [76].